Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Apyx Medical Corporation APYX |
Nantahala Capital Management, LLC | 3,493,235 9.990% |
3,493,235 (New Position) |
Filing History |
| 2024-10-31 5:44 pm Sale |
2024-10-31 | 13G | Apyx Medical Corporation APYX |
Archon Capital Management LLC | 3,115,281 8.990% |
-336,749 (-9.76%) |
Filing History |
| 2024-10-15 09:18 am Purchase |
2024-09-30 | 13G | Apyx Medical Corporation APYX |
ROYCE & ASSOCIATES LLC | 2,582,490 7.450% |
423,590 (+19.62%) |
Filing History |
| 2024-05-09 07:45 am Unchanged |
2024-05-07 | 13D | Apyx Medical Corporation APYX |
Vizirgianakis Stavros G. | 1,746,191 5.040% |
0 (Unchanged) |
Filing History |
| 2024-04-05 09:00 am Unchanged |
2024-03-29 | 13D | Apyx Medical Corporation APYX |
Archon Capital Management LLC | 3,452,030 9.960% |
0 (Unchanged) |
Filing History |
| 2024-04-01 4:15 pm Purchase |
2024-03-25 | 13D | Apyx Medical Corporation APYX |
Vizirgianakis Stavros G. | 1,746,191 5.040% |
1,746,191 (New Position) |
Filing History |
| 2024-03-25 9:52 pm Sale |
2024-03-22 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 0 0.000% |
-2,040,540 (Position Closed) |
Filing History |
| 2024-02-14 5:06 pm Sale |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
Pura Vida Investments, LLC | 80,000 0.230% |
-2,207,560 (-96.50%) |
Filing History |
| 2024-02-14 3:05 pm Sale |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
Divisadero Street Capital Management, LP | 0 0.000% |
-2,056,799 (Position Closed) |
Filing History |
| 2024-02-14 07:32 am Sale |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
RTW Investments, LP | 1,025,963 3.000% |
-2,372,316 (-69.81%) |
Filing History |
| 2024-02-13 10:58 am Unchanged |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
Archon Capital Management LLC | 3,452,030 9.960% |
0 (Unchanged) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 2,040,540 5.900% |
156,259 (+8.29%) |
Filing History |
| 2024-02-02 11:56 am Sale |
2023-12-29 | 13G | Apyx Medical Corporation APYX |
Cowen Financial Products LLC | 0 0.000% |
-1,775,793 (Position Closed) |
Filing History |
| 2024-01-23 09:52 am Unchanged |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
ROYCE & ASSOCIATES LLC | 2,158,900 6.230% |
0 (Unchanged) |
Filing History |
| 2024-01-23 09:49 am Purchase |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
ROYCE & ASSOCIATES LLC | 2,158,900 6.230% |
2,158,900 (New Position) |
Filing History |
| 2023-08-14 08:00 am Purchase |
2023-08-11 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 1,884,281 5.400% |
197,805 (+11.73%) |
Filing History |
| 2023-06-12 8:59 pm Sale |
2023-06-06 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 1,686,476 4.900% |
-309,524 (-15.51%) |
Filing History |
| 2023-05-19 5:17 pm Purchase |
2023-05-18 | 13G | Apyx Medical Corporation APYX |
Divisadero Street Capital Management, LP | 2,056,799 5.900% |
2,056,799 (New Position) |
Filing History |
| 2023-05-12 06:42 am Purchase |
2023-05-11 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 1,996,000 5.800% |
1,996,000 (New Position) |
Filing History |
| 2023-02-14 2:45 pm Sale |
2022-12-31 | 13G | Apyx Medical Corporation APYX |
Pura Vida Investments, LLC | 2,287,560 6.610% |
-207,877 (-8.33%) |
Filing History |